Drilldown: Medicines
Appearance
Medicines > classes
:
Benzodiazepine
or
Cathinone
or
[[:Category:Dibenzothiazepines|Dibenzothiazepine]] 
:
Benzodiazepine
or
Cathinone
or
[[:Category:Dibenzothiazepines|Dibenzothiazepine]] 
Use the filters below to narrow your results.
3-MMC (1) ·
Alprazolam (1) ·
Bromazepam (1) ·
Butylone (1) ·
Cathinone (1) ·
Chlordiazepoxide (1) ·
Clobazam (1) ·
Clonazolam (1) ·
Clorazepate (1) ·
Diclazepam (1) ·
Ephylone (1) ·
Estazolam (1) ·
Ethcathinone (1) ·
Ethylone (1) ·
Flualprazolam (1) ·
Flubromazepam (1) ·
Flubromazolam (1) ·
Flunitrazepam (1) ·
Flunitrazolam (1) ·
Flurazepam (1) ·
Hexedrone (1) ·
Lormetazepam (1) ·
Mephedrone (1) ·
Methcathinone (1) ·
Methylone (1) ·
Mexedrone (1) ·
Midazolam (1) ·
N-Ethylhexedrone (1) ·
N-Ethylpentedrone (1) ·
Nifoxipam (1) ·
Nitrazepam (1) ·
Oxazepam (1) ·
Pentedrone (1) ·
Pyrazolam (1) ·
Quazepam (1) ·
Quetiapine (1) ·
Temazepam (1) ·
Triazolam (1)
None (23) ·
Dalmane (1) ·
Doral (1) ·
Halcion (1) ·
Lexotan (1) ·
Librium (1) ·
Mogadon (1) ·
Onfi (1) ·
ProSom (1) ·
Restoril (1) ·
Rohypnol (1) ·
Serax (1) ·
Seroquel (1) ·
Tranxene (1) ·
Versed (1) ·
Xanax (1)
Cathinone analogue; monoamine reuptake inhibitor (2) ·
Dopamine D2 and serotonin 5-HT2A receptor antagonist'"`UNIQ--ref-0000008D-QINU`"' '"`UNIQ--vote-0000008E-QINU`"' (1) ·
Extremely potent GABAA positive allosteric modulator (1) ·
GABA-A positive allosteric modulator'"`UNIQ--ref-00000067-QINU`"' '"`UNIQ--vote-00000068-QINU`"' (1) ·
GABAA positive allosteric modulator (18) ·
GABAA positive allosteric modulator; low sedation (1) ·
GABAA positive allosteric modulator; prodrug of desmethyldiazepam (1) ·
GABAA positive allosteric modulator; very long half-life (1) ·
Monoamine releasing agent (4) ·
Monoamine releasing agent; active ingredient in khat (1) ·
Norepinephrine and dopamine releasing agent (1) ·
Norepinephrine/dopamine releasing agent (1) ·
Norepinephrine/dopamine reuptake inhibitor (1) ·
Serotonin releasing agent; monoamine reuptake inhibitor (1) ·
Serotonin/norepinephrine/dopamine releasing agent (3)
None (36) ·
0.25 mg, 0.5 mg, 1 mg, 2 mg tablets (immediate-release and orally disintegrating); 0.5 mg, 1 mg, 2 mg, 3 mg extended-release tablets; 1 mg/mL oral concentrate (1) ·
25 mg, 50 mg, 100 mg, 200 mg, 300 mg, 400 mg immediate-release tablets; 50 mg, 150 mg, 200 mg, 300 mg, 400 mg extended-release tablets (Seroquel XR) (1)
None (36) ·
Category D'"`UNIQ--ref-0000006C-QINU`"' (1) ·
Pregnancy categories were retired by FDA in 2015. Quetiapine has reassuring active-comparator cohort data without consistent teratogenic signal; among the preferred neuroleptics when treatment is clinically necessary in pregnancy. See pregnancy_details for the full citation set. (1)
Showing below up to 38 results in range #1 to #38.

